Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | MMP12 | P39900 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | FABP7 | O15540 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | STS | P08842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887996 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL28231200 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL29387319 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL18823067 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL18823065 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL11658796 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL33402 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL645382 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL437640 | 1.00 | EPHX1 (0.45) | EPHX1CA12CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL12981077 | 0.98 | EPHX1 (0.44) | EPHX1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112040926-B | Covalent treatment of keratin-containing materials with thiols | 生活实验公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117860615-A | Covalent treatment of keratin-containing materials | 生活实验公司 | 2024-04-12 | — | — | CN | claimed |
| US-20230225952-A1 | ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2023-07-20 | — | — | US | claimed |
| EP-3989920-A1 | ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF | Living Proof, Inc. (US) | 2022-05-04 | — | — | EP | claimed |
| CN-114222555-A | Additives for colorants and methods of use thereof | 生活实验公司 | 2022-03-22 | — | — | CN | claimed |
| EP-3755302-A1 | COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS | Living Proof, Inc. (US) | 2020-12-30 | — | — | EP | claimed |
| WO-2020264257-A1 | ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2020-12-30 | — | — | WO | claimed |
| CN-112040926-A | Covalent treatment of keratin-containing materials with thiols | 生活实验公司 | 2020-12-04 | — | — | CN | claimed |
| CN-111936117-A | Covalent treatment of keratin-containing materials | 生活实验公司 | 2020-11-13 | — | — | CN | claimed |
| EP-3709964-A1 | COVALENT TREATMENT FOR KERATIN-CONTAINING MATERIALS | Living Proof, Inc. (US) | 2020-09-23 | — | — | EP | claimed |
| WO-2019164841-A1 | COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS | LIVING PROOF, INC. (US) | 2019-08-29 | — | — | WO | claimed |
| US-20190160001-A1 | COVALENT TREATMENT FOR KERATIN-CONTAINING MATERIALS | LIVING PROOF, INC. | 2019-05-30 | — | — | US | claimed |
| US-10150008-B1 | Golf balls incorporating mixtures of a thermoplastic polymer and polymethyl methacrylate-based polymers | ACUSHNET COMPANY (US) | 2018-12-11 | — | — | US | claimed |
| EP-0312228-B2 | Polymeric additives for use in adhesive compositions | ROHM & HAAS (US) | 1997-09-17 | — | — | EP | claimed |
| EP-0312228-A1 | Polymeric additives for use in adhesive compositions | ROHM AND HAAS COMPANY (US) | 1989-04-19 | — | — | EP | claimed |
| US-12638789-B2 | Toner and two-component developer | CANON KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-122094988-A | Iodine-containing (meth) acrylate compound, iodine-containing (meth) acrylate (co) polymer, composition for lithography, resist composition, composition for underlayer film formation, and method for producing iodine-containing (meth) acrylate compound | — | 2026-05-26 | — | — | CN | disclosed |
| US-4158736-A | ANIONIC POLYMERIZATION | ROHM AND HAAS COMPANY (US) | 1979-06-19 | — | — | US | disclosed |
| US-4126595-A | Aqueous coating compositions comprising acrylic oligomers, high molecular weight polymers and crosslinkers | ROHM AND HAAS COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-4087397-A | Aqueous coating compositions comprising acrylic oligomers and high molecular weight polymers | ROHM AND HAAS COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12638789-B2 | Toner and two-component developer | TMPO, BET1, SRMS | EPHX1 2262/4885CA12 74/4885CA1 112/4885 |
| US-20230225952-A1 | ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF | COXFA4L2, TYR, OAT | EPHX1 2098/4885CA12 524/4885CA1 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.